Back

Two-Lead DX-based versus conventional three-Lead CRT-D: a single centre experience

13 April 2026 (08:00 - 18:15)
Organised by: Logo
Congress Presentation Part of: Poster session (2): device therapy Cardiac Resynchronisation Therapy (CRT) EHRA Premium Access EHRA 2026 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Alessandro Carecci

University Hospital of Bologna S. Orsola-Malpighi Polyclinic, Bologna (Italy)

210 More presentations in this session

Presentation thumbnail
Genetic variants and device upgrade in young pacemaker recipients
Doctor J. Sanchez Moreno (Almeria, ES)
Abstract Slides Video
Presentation thumbnail
Electrocardiographic repolarization changes following conduction system pacing in pacemaker-induced cardiomyopathy
Doctor A. Sahin (Konya, TR)
Abstract Slides Video
Presentation thumbnail
Experiences with implantable loop recorders in syncope patients
Mr A. Oinonen (Helsinki, FI)
Abstract Slides Video
Presentation thumbnail
Forcecardiography as a non-invasive predictor of echocardiographic parameters in patients undergoing cardiac resynchronization therapy: a preliminary study
Doctor V. Pergola (Naples, IT)
Abstract
Presentation thumbnail
Diagnostic work-up and clinical characteristics in out-of-hospital cardiac arrest survivors with ICD implantation: a prospective Danish study
Mr C. Hansen (Copenhagen, DK) Doctor B. Winkel (Copenhagen, DK)
Abstract

Access the full session

Session thumbnail
Poster session (2): device therapy

The Event

Event poster

EHRA 2026

13 April 2026 08:00 CET
You may be interested in
thumbnail
Congress Presentation
The role of atrial pacing support in cardiac resynchronisation therapy in patients without sinus node dysfunction: a non-inferiority randomised trial
thumbnail
Congress Presentation
Clinical performance and safety of a two-lead cardiac resynchronization therapy system with a floating atrial sensing dipole.
thumbnail
Congress Presentation
Assessing the response to cardiac resynchronization therapy in heart failure patients: a comparative analysis between transvenous and epicardial leads.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources